The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 16, 2017
Filed:
Jul. 13, 2016
Applicant:
Rosetta Genomics Ltd., Rehovot, IL;
Inventors:
Itzhak Bentwich, Tel Aviv, IL;
Amir Avniel, Tel Aviv, IL;
Yael Karov, Tel Aviv, IL;
Ranit Aharonov, Tel Aviv, IL;
Assignee:
Rosetta Genomics Ltd., Rehovot, IL;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C07H 21/04 (2006.01); C12Q 1/68 (2006.01); A61K 38/00 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); A61K 38/00 (2013.01); C12N 15/111 (2013.01); C12N 15/113 (2013.01); C12Q 1/6809 (2013.01); C12N 2310/14 (2013.01); C12N 2310/141 (2013.01); C12N 2310/531 (2013.01); C12N 2320/10 (2013.01); C12N 2320/11 (2013.01); C12N 2320/30 (2013.01); C12N 2330/10 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/16 (2013.01); C12Q 2600/178 (2013.01);
Abstract
Described herein are novel polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.